Chapter 15 : Prevention of Infection in Xenotransplantation

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Prevention of Infection in Xenotransplantation, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818043/9781555811679_Chap15-1.gif /docserver/preview/fulltext/10.1128/9781555818043/9781555811679_Chap15-2.gif


The central hypothesis for this chapter is that some of the infectious risks associated with xenotransplantation can be assessed before the broad application of this emerging technology. Epidemiologic exposures in the transplant recipient take two forms: those occurring within the hospital or the community, and those exposures carried with the transplanted organ. On the basis of experience with human allograft recipients and with immunosuppressed miniature swine, common infections in the first month after xenotransplantation are likely to be due to bacteria and fungi common to swine and to primates: staphylococci, streptococci, spp., spp., spp., and spp., which are routinely isolated from swine and from non-human primates. With prolonged xenograft survival, the susceptibility of the xenograft recipient to infection reflects the individual's epidemiologic exposures and the immune suppression and manipulations of donor and host needed to prevent graft rejection. While breeding strategies may enhance the safety of xenotransplantation, the greatest potential risk to the recipient and to the general community by xenograft-derived organisms may be due to infection by unknown pathogens that cause minimal or novel clinical syndromes and for which clinical laboratory testing is not available. Chimerism and False Positive Assays for Infection of the Host and Routine Monitoring for Xenogeneic Infection are among the issues discussed for maintaining safety in clinical trials of xenotransplantation. Further research is essential regarding the behavior of organisms known to be present in prospective donor species in xenograft recipients and on the detection of novel potential pathogens.

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15

Key Concept Ranking

Simian immunodeficiency virus
Rous sarcoma virus
Murine leukemia virus
Simian foamy virus
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Porcine endogenous retrovirus replicating in human 293 kidney cells (x60,000). Provided by Drs. K. Boiler, R. R. Tonjes, J. Denner, Paul-Ehrlich Institute, Langen, Germany.

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Northern analysis of the expression of PERV-MSL (PERV C) in various tissues. A probe for the region of PERV was hybridized to poly-A+ RNA (0.5 g) from each tissue indicated and from normal peripheral blood lymphocytes (PBL, lane 1) and PHA-activated lymphocytes (PHA PBL, lane 2), PK15 cells (0.04 lanes 3 and 11). Expression of PERV was detected in all porcine cells and tissues analyzed (including kidney and heart with longer exposures). The expression of PERV is increased by stimulation with the mitogen PHA (reprinted from reference 1, with permission).

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Strategy for the evaluation of xenograft recipients with signs or symptoms of infection.

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Akiyoshi, D. E.,, M. Denaro,, H. Zhu,, J. L. Greenstein,, P. Banerjee,, and J. A. Fishman. 1998. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J. Virol. 72:45034507.
2. Assaf, R.,, A. M. P. Bouillant,, and E. DiFranco. 1982. Enzyme linked immunosorbent assay (ELISA) for the detection of antibodies to porcine cytomegalovirus. Can. J. Comp. Med. 46:183185.
3. Barbacid, M.,, D. Bolognesi,, and S. A. Aaronson. 1980. Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in reponse to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc. Natl. Acad. Set USA 77:16171621.
4. Barnett, S. W.,, K. K. Murthy,, B. G. Herndier,, and J. A. Levy. 1994. An AIDS-like condition induced in baboons by HIV-2. Science 266:642646.
5. Bjoersdorff, A.,, O. Korsgren,, R. Feinstein,, A. Andersson,, J. Tollemar,, A.-S. Malmborg,, A. Ehrnst,, and C. G. Groth. 1995. Microbiological characterization of porcine fetal islet-like cell clusters for intended clinical xenografting. Xenotransplantation 2:2631.
6. Bouillant, A. M. P.,, A. S. Greig,, and P. Genest. 1973. Biological characterization of cell line derived from the pig oviduct. In Vitro 9:92102.
7. Bouilant, A. M. P.,, A. S. Grieg,, M. M. Lieber,, and G. J. Todaro. 1975. Type-C virus production by a continuous line of pig oviduct cells (PFT). J. Gen. Virol. 27:173180.
8. Bowden, R. A.,, R. W. Coombs,, B. H. Nikora,, C. Bigelow,, G. E. Sale,, D. Thomas,, J. D. Meyers,, and L. Corey. 1990. Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation. Am. J. Med. 88:5–49N5–52N.
9. Carbone, M.,, H. I. Pass,, P. Rizzo,, M. Marinetti,, M. DiMuzio,, D. J. Mew,, A. S. Levine,, and A. Procopio. 1994. Simian virus-40-like DNA sequences in human pleural mesothelioma. Oncogene 9:17811790.
10. Cen, H.,, M. C. Breinig,, R. W. Atchinson,, M. Ho,, and J. L. C. McKnight. 1991. Epstein-Barr virus transmission via the donor organs in solid organ transplantation polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3 and IR4. J. Virol. 65:976980.
11. Chang, Y.,, E. Cesarman,, M. S. Pessin,, F. Lee,, J. Culpepper,, D. M. Knowles,, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS- associated Kaposi's sarcoma. Science 266:18651869.
12. Christensen, L. S.,, K. J. Sorensen,, B. S. Strandby-Gaard,, C. A. Henrikson,, and J. B. Anderson. 1990. Evidence of long distance airborne transmission of Aujeszky's disease virus-1, identification of emerging strains, p. 206. Proc. 11th Int. Congr. Pig Vet. Soc. University of Iowa, Ames.
13. Christensen, S. G. 1987. Co-ordination of a nationwide survey on the presence of Yersinia enterocolitica 0:3 in the environment of butcher shops. Contrib. Microbiol. Immunol. 9:2629.
14. Dummer, J. S.,, J. Armstrong,, J. Somers,, S. Kusne,, B. J. Carpenter,, J. T. Rosenthal,, and M. Ho. 1987. Transmission of infection with herpes simplex by renal transplantation. J. Infect. Dis. 155:202206.
15. Dummer, J. S.,, S. Erb,, M. K. Breinig,, M. Ho,, C. R. Rinaldo, Jr.,, P. Gupta,, M. V. Ragni,, A. Tzakis,, L. Makowka,, D. Van Thlel, et al. 1989. Infection with human immunodeficiency virus in the Pittsburgh transplant population. Transplantation 47:134139.
16. Ebert, D. 1998. Experimental evolution of parasites. Science 282:14321435.
17. Edington, N.,, S. Broad,, A. E. Wrathall,, and J. T. Done. 1988. Superinfection with porcine cytomegalovirus-initiation by transplacental infection. Vet. Microbiol. 16:189193.
18. Edington, N.,, A. E. Wrathall,, and J. T. Done. 1988. Porcine cytomegalovirus (PCMV) in early gestation. Vet. Microbiol. 17:117128.
19. Emery, D. W.,, M. Sykes,, D. H. Sachs,, and C. LeGuern. 1994. Mixed swine/human long-term bone marrow cultures. Transplant. Proc. 26:13131314.
20. Erice, A.,, F. S. Rhame,, R. C. Heussner,, D. L. Dunn,, and H. H. Balfour. 1991. Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev. Infect. Dis. 13:747.
21. Fishman, J. A. 1994. Miniature swine as organ donors for man: strategies for prevention of xenotransplant-associated infections. Xenotransplantation 1:4757.
22. Fishman, J. A. 1997. Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology. Kidney Int. 51(Supp 58):4115.
23. Fishman, J. A.,, and R. H. Rubin. 1998. Infection in organ transplant recipients. N. Engl. J. Med. 338:17411751.
24. Fraumeni, J. F., Jr.,, F. Ederer,, and R. W. Miller. 1963. An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 185:713718.
25. Galili, U.,, M. R. Clark,, S. B. Shohet,, J. Buehler,, and B. A. Macher. 1987. Evolutionary relationship between the natural anti-Gal antibody and the GalaGal epitope in primates. Proc. Natl. Acad. Set USA 84:13691373.
26. Gloster, J.,, R. F. Sellers,, and A. I. Donaldson. 1982. Long distance transport of foot-and-mouth disease virus over sea. Vet. Rec. 100:4752.
27. Groth, C. G.,, O. Korsgren,, A. Tibell,, J. Tollemar,, E. Moller,, J. Bolinder,, J. Ostman,, F. P. Reinholt,, C. Hellerstrom,, and A. Andersson. 1994. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:14021404.
28. Guberan, E.,, M. Usel,, L. Raymond,, and G. Fioretta. 1993. Mortality and incidence of cancer among a cohort of self employed butchers from Geneva and their wives. Br. J. Ind. Med. 50:10081016.
29. Hamadeh, R. M.,, G. A. Jarvis,, U. Galili,, R. E. Mandrell,, P. Zhou,, and J. M. Griffiss. 1992. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J. Clin. Invest. 89:12231235.
30. Heneine, W.,, W. M. Switzer,, P. Sandstrom,, J. Brown,, S. Vedapuri,, C. A. Schable,, A. S. Khan,, N. W. Lerche,, M. Schweizer,, D. Neumann-Haefelin,, L. E. Chapman,, and T. M. Folks. 1998. Identification of a human population infected with simian foamy viruses [see comments]. Nature Med. 4:403407.
31. Heneine, W.,, A. Tibell,, W. M. Switzer,, P. Sandstrom,, G. Vazquez Rosales,, A. Mathews,, O. Korsgren,, L. E. Chapman,, T. M. Folks,, and C. G. Groth. 1998. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 352:695699.
32. Henretta, J.,, T. McFadden,, K. Pittman,, J. Thomas,, and F. Thomas. 1994. Six- to eight-month survival of discordant pig islet xenografts documented by differential species, insulin, and C-peptide in animals given short-term immunosuppression. Transplant. Proc. 26:11381139.
33. Hinshaw, V. S.,, W. J. Bean, Jr.,, R. G. Webster,, and B. C. Easterday. 1978. The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine. Virology 84:5162.
34. Hirsch, M. S. 1976. Immunologic activation of endogenous oncogenic viruses. Ann. N.Y. Acad. Sci. 276:529535.
35. Hirsch, M. S.,, D. A. Ellis,, P. A. Black,, A. P. Monaco,, and M. L. Wood. 1973. Leukemia virus activation during homograft rejection. Science 180:500502.
36. Hirsch, M. S.,, S. M. Phillips,, C. Solnik,, P. H. Black,, R. S. Schwartz,, and C. B. Carpenter. 1972. Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc. Natl. Acad. Sci. USA 69:10691072.
37. Ho, M.,, G. Miller,, R. W. Atchison,, M. K. Breinig,, J. S. Dummer,, W. Andiman,, T. E. Starzl,, R. Eastman,, B. P. Griffith,, R. L. Hardesty, et al. 1985. Epstein-Barr virus infections and DNA hybridization studies in post transplantation lymphoma and lymphoproliferative lesions the role of primary infection. J. Infect. Dis. 152:876886.
38.Institute of Medicine. 1992. Emerging Infections: Microbial Threats to Health in the United States. National Academy Press, Washington, D.C.
39. Irwin, D. M.,, T. D. Kocher,, and A. C. Wilson. 1991. Evolution of the cytochrome B gene of mammals. J. MolEvol. 32:128144.
40. Isfort, R.,, D. Jones,, R. Kost,, R. Witter,, and H. Kung. 1992. Retrovirus insertion into herpesvirus in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89:991995.
41. Javier, R. T.,, F. Sedarati,, and J. G. Stevens. 1986. Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science 234:746748.
42. Kaeffer, B.,, E. Bottreau,, L. P. Thanh,, M. Olivier,, and H. Salmon. 1990. Histocompatible miniature boar model: selection of transformed cell lines of B and T lineages producing retrovirus. Int. J. Cancer 46:481488.
43. Kanitz, C. L.,, and M. E. Woodruff. 1976. Cell culture indirect fluorescence antibody studies of porcine cytomegalovirus, p. 9. In Proc. 4th Int. Pig Vet. Soc. Congress. University of Iowa, Ames.
44. Katz, R. A., and A. M. Skalka. 1990. Generation of diversity in retroviruses. Annu. Rev. Genet. 24:409405.
45. Kaufhold, A.,, R. Lutticken,, and S. Litterscheid. 1988. Systemic infection caused by Streptococcus suis. Deutsche Med. Wochenschrift 113:16421643.
46. Khabbaz, R. F.,, W. Heneine,, J. R. George,, B. Parekh,, T. Rowe,, T. Woods,, W. M. Switzer,, H. M. McClure,, M. Murphey-Corb,, and T. M. Folks. 1994. Infection of a laboratory worker with simian immunodeficiency virus. N. Engl. J. Med. 330:172177.
47. Kohler, W.,, H. Queisser,, E. Kunter,, R. Sawitzki,, and G. Frach. 1989. Type 2 Streptococcus suis (R-streptococci) as pathogens of occupational diseases. Report of a case and a review of the literature. Zeitschrift Gesamte Inn. Med. Grenzgebiete 44:144148.
48. Levin, J. L.,, J. K. Hilliard,, S. L. Lipper,, T. M. Butler,, and W. J. Goodwin. 1988. A naturally occurring epizootic of simian agent 8 in the baboon. Lab. Animal. Sci. 38:394397.
49. Levy, J. A. 1977. Murine xenotropic type C viruses. III. Phenotypic mixing with avian leukosis and sarcoma viruses. Virology 77:811825.
50. Lieber, M. M.,, C. H. Sherr,, R. E. Benveniste,, and C. J. Todaro. 1975. Biologic and immunologic properties of porcine type C virus. Virology 66:616.
51. Lusso, P.,, F. Di Marzo Veronese,, B. Ensoli,, G. Franchini,, C. Jemma,, S. E. De Rocco,, V. S. Kalyanaraman,, and R. C. Gallo. 1990. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247:848852.
52. Marchetti, P.,, D. W. Scharp,, J. Longwith,, C. Swanson,, B. Olack,, A. Gerasimidi-Vazeou,, E. H. Finke,, and P. E. Lacy. 1992. Prevention of contamination of isolated porcine islets of Langerhans. Transplantation 53:13641366.
53. Martin, U.,, V. Kiessig,, J. H. Blusch,, A. Haverich,, K. von der Helm,, T. Herden,, and G. Steinhoff. 1998. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 352:692694.
54. McClure, M. O.,, Q. J. Sattentau,, P. C. Beverley,, J. P. Hearn,, A. K. Fitzgerald,, A. J. Zuckerman,, and R. A. Weiss. 1987. HIV infection of primate lymphocytes and conservation of the CD4 receptor. Nature 330:487489.
55. McCurry, K. R.,, D. L. Kooyman,, C. G. Alvarado,, A. H. Cotterell,, M. J. Martin,, J. S. Logan,, and J. L. Piatt. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1:423427.
56. Merilahti-Palo, R.,, R. Lahesmaa,, K. Granfors,, C. Gripenberg-Lerche,, and P. Toivanen. 1991. Risk of Yersinia infection among butchers. Scand. J. Infect. Dis. 23:5561.
57. Metzger, J. J.,, G. L. Gilliland,, J. K. Lunney,, B. A. Osborne,, S. Rudikoff,, and D. H. Sachs. 1981. Transplantation in miniature swine. IX. Swine histocompatibility antigens isolation and purification of papain-solubilized SLA antigens. J. Immunol. 127:769775.
58. Michaels, M. G.,, R. Lanford,, A. J. Demetris,, D. Chavez,, K. Brasky,, J. Fung,, and T. E. Starzl. 1996. Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation 61:350351.
59. Michaels, M. G.,, and R. L. Simmons. 1994. Xenotransplant-associated zoonoses: strategies for prevention. Transplantation 57:17.
60. Morsiani, E.,, L. Cappellari,, L. Fogli,, D. Ricci,, C. Puviani,, and G. Azzena. 1992. Xenograft of piscine insular tissue in nude streptozotocin-diabetic mice: a transplantation model. Transplant. Proc. 24:672673.
61. Murphy, B. R.,, and R. G. Webster,. 1990. Orthomyxoviruses, p. 10911152. In B. N. Fields, and D. M. Knipe (ed.), Virology. Raven Press, Ltd., New York, N.Y.
62. Narita, M.,, M. Shimizu,, H. Kawamura,, M. Haritani,, and M. Moriawaki. 1987. Pathologic changes in pigs with prednisolone-induced recrudescence of herpesvirus infection. Am. J. Vet. Res. 48:13981402.
63. Olding, L. B.,, F. C. Jensen,, and M. B. Oldstone. 1975. Pathogenesis of cytomegalovirus infection. I. Activation of virus from bone-derived lymphocytes by in vitro allogeneic reaction. J. Exp. Med. 141:561566.
64. Patience, C.,, G. S. Patton,, S. Takeuchi,, R. A. Weiss,, M. O. McClure,, L. Rydberg,, and M. E. Breimer. 1998. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 352:699701.
65. Patience, C.,, Y. Takeuchi,, and R. A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3:276282.
66. Pereira, B. J. G.,, E. L. Milford,, R. L. Kirkman,, and A. S. Levey. 1991. Transmission of hepatitis C virus by organ transplantation. N. Engl. J. Med. 325:454460.
67. Pirtle, E. C. 1973. Incidence of antibody to swine influenza virus in Iowa breeder and butcher pigs correlated with signs of influenza-like illness. Am. J. Vet. Res. 34:8385.
68. Rando, R. F.,, A. Srinivasan,, J. Feingoid,, E. Gonczol,, and S. Plotkin. 1990. Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology 176:8797.
69. Rosengard, A. M.,, N. R. B. Cary,, G. A. Langford,, A. W. Tucker,, J. Wallwork,, and D. J. G. White. 1995. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 59:13251333.
70. Rothe, J.,, P. J. McDonald,, and A. M. Johnson. 1985. Detection of Toxoplasma cysts and oocysts in an urban environment in a developed country. Pathology 17:497499.
71. Rother, R. P.,, W. L. Fodor,, J. P. Springhorn,, C. W. Birks,, E. Setter,, M. S. Sandrin,, S. P. Squinto,, and S. A. Rollins. 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-a-galactosyl natural antibody. J. Exp. Med. 182:13451355.
72. Rubin, R. H.,, and N. E. Tolkoff-Rubin. 1988. The problem of human immunodeficiency virus (HIV) infection and transplantation. Transplant. Immunol. 1:3638.
73. Sachs, D. H.,, G. Leight,, J. Cone,, S. Schwarz,, L. Stuart,, and S. Rosenberg. 1976. Transplantation in miniature swine: I. Fixation of the major histocompatibility complex. Transplantation 22:559567.
74. Sandrin, M. S.,, W. L. Fodor,, E. Mouhtouris,, N. Osman,, S. Cohney,, S. A. Rollins,, E. R. Guilmette,, E. Setter,, S. P. Squinto,, and I. F. C. McKenzie. 1995. Enzymatic remodelling of the carbohydrate surface of a senogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med. 1:12611267.
75. Sandrin, M. S.,, H. A. Vaughan,, and I. F. C. McKenzie. 1994. Identification of Gal(al,3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplant. Rev. 8:134149.
76. Schnurrenberger, P. R.,, G. T. Woods,, and R. J. Martin. 1970. Serologic evidence of human infection with swine influenza virus. Am. Rev. Respir. Dis. 102:356361.
77. Schwarz, A.,, G. Offermann,, F. Keller,, I. Bennhold,, J. L'Age-Stehr,, P. H. Krause,, and M. J. Mihatsch. 1993. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation—data on four cases and review of the literature. Transplantation 55:95103.
78. Shah, K. V.,, H. L. Ozer,, H. S. Pond,, L. D. Palma,, and G. P. Murphy. 1971. SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature 231:448449.
79. Shope, R. E. 1931. Swine influenza. III. Filtration experiments and etiology. J. Exp. Med. 54:373380.
80. Simonds, R. J.,, S. D. Holmberg,, R. L. Hurwitz,, T. R. Coleman,, S. Bottenfield,, L. J. Conley,, S. H. Kohlenberg,, K. G. Castro,, B. A. Dahan,, C. A. Schable, et al. 1992. Transmission of human immunodeficiency virus type I from a seronegative organ and tissue donor. N. Engl. J. Med. 326:726732.
81. Smith, D. M. 1993. Endogenous retroviruses in xenografts. N. Engl. J. Med. 328:141142.
82. Snyder, H. W., Jr.,, and E. Fleissner. 1980. Specificity of human antibodies to oncovirus glycoproteins: recognition of antigen by natural antibodies directed against carbohydrate structures. Proc. Natl. Acad. Sci. USA 77:16221626.
83. Specter, D. H.,, E. Wade,, D. A. Wright,, V. Koval,, C. Clark,, D. Jaquish,, and S. A. Specter. 1990. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64:22982308.
84. Starzl, T. E.,, J. Fung,, A. Tzakis,, S. Todo,, A. J. Demetris,, I. R. Marino,, H. Doyle,, A. Zeevi,, V. Warty,, M. Michaels, et al. 1993. Baboon to human liver transplantation. Lancet 341:6571.
85. Starzl, T. E.,, A. Tzakis,, J. J. Fung,, S. Todo,, A. J. Demetris,, R. Manez,, I. R. Marino,, L. Valdivia,, and N. Muase. 1994. Prospects of clinical xenotransplantation. Transplant. Proc. 26:10821088.
86. Stoye, J. P.,, and J. M. Coffin. 1988. Polymorphism of murine endogenous proviruses revealed by using virus class-specific oligonucleotide probes. J. Virol. 62:168175.
87. Stoye, J. P.,, and J. M. Coffin,. 1985. Endogenous viruses, p. 357. In R. Weiss,, N. Teich,, H. Varmus,, and J. Coffin (ed.), RNA Tumor Viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
88. Sugimura, T.,, H. Yonemochi,, T. Ogawa,, Y. Tanaka,, and T. Kumagai. 1980. Isolation of a recombinant influenza virus (HswlN2) from swine in Japan. Arch. Virol. 66:271274.
89. Suzuka, I.,, K. Sekiguchi,, and M. Kodama. 1985. Some characteristics of a porcine retrovirus from a cell line derived from swine malignant lymphomas. FEBS 183:124128.
90. Suzuki, T.,, T. M. Sundt,, E. O. Kortz,, A. Mixon,, M. A. Eckhaus,, R. E. Gress,, T. R. Spitzer,, and D. H. Sachs. 1989. Bone marrow transplantation across an MHC barrier in miniature swine. Transplant. Proc. 21:30763078.
91. Sweet, B. H.,, and M. R. Hilleman. 1960. The vacuolating virus: SV40 (26128). Proc. Soc. Exp. Biol. Med. 105:420427.
92. Tacal, J. V., Jr.,, M. Sobieh,, and A. el-Ahraf. 1987. Cryptosporidium in market pigs in southern California, USA. Vet. Rec. 120:615616.
93. Todaro, G. J.,, R. E. Benveniste,, M. M. Lieber,, and C. J. Sherr. 1974. Characteristics of a type C virus released from the porcine cell line PK(15). Virology 58:6574.
94. Todd, K. H.,, and P. D. Lyde. 1989. Brucellosis and thrombocytopenic purpura: case report and review. Texas Med. 85:3738.
95. Weiss, R. A.,, and A. L. Wong. 1977. Phenotypic mixing between avian and mammalian RNA tumor viruses: 1. Envelope pseudotypes of Rous sarcoma virus. Virology 76:826834.
96. Welsh, R. M.,, N. R. Cooper,, F. C. Jensen,, and M. B. A. Oldstone. 1975. Human serum lyses RNA tumour viruses. Nature 257:612614.
97. Welsh, R. M.,, F. C. Jensen,, N. R. Cooper,, and M. B. A. Oldstone. 1976. Inactivation and lysis of oncornaviruses by human serum. Virology 74:432440.
98. Wilson, C. A.,, S. Wong,, J. Muller,, C. E. Davidson,, T. M. Rose,, and P. Burd. 1998. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol. 72:30823087.
99. Winkler, G. C.,, and N. F. Cheville. 1986. Ultrastructural morphometric investigation of early lesions in the pulmonary alveolar region of pigs during experimental swine influenza infection. Am. J. Pathol. 122:541552.
100. Ye, Y.,, M. Niekrasz,, S. Kosanke,, R. Welsh,, H. E. Jordan,, J. C. Fox,, W. C. Edwards,, C. Maxwell,, and D. K. C. Cooper. 1994. The pig as a potential organ donor for man. A study of potentially transferable disease from donor pig to recipient man. Transplantation 57:694703.
101. Ye, Y.,, M. Niekrasz,, R. Welsh,, S. Kosanke,, C. Maxwell,, N. Zuhdi,, and D. K. C. Cooper. 1994. A practical study of zoonoses that could complicate pig-to-man organ transplantation. Transplant. Proc. 26:1312.


Generic image for table
Table 1

Nonrecognition of infection associated with xenograft transplantation

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Generic image for table
Table 2

Infectious considerations for non-human primates in xenotransplantation

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Generic image for table
Table 3

Microbial agents of swine known to cause infection in humans

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Generic image for table
Table 4

Categories of potential pathogens resulting from xenotransplantation

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Generic image for table
Table 5

Screening xenograft source animals: microbiologic exclusion criteria

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Generic image for table
Table 6

Designated-pathogen-free miniature swine for xenotransplantation

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15
Generic image for table
Table 7

Microbiologic screening of animal handlers

Citation: Fishman J. 2001. Prevention of Infection in Xenotransplantation, p 261-290. In Platt J (ed), Xenotransplantation. ASM Press, Washington, DC. doi: 10.1128/9781555818043.ch15

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error